Haryana Flags Over 30 Drug Overcharging Cases, Seeks NPPA Action Written By Parthika Patel6 Jan 2026 3:11 PM ISTChandigarh: The Haryana government has forwarded 33 cases of alleged overcharging of medicines to the National Pharmaceutical Pricing Authority (NPPA)...
Health Ministry Mulls Extension for Pharma Firms to Comply with Revised Schedule M GMP Norms Written By Parthika Patel6 Jan 2026 2:53 PM ISTNew Delhi: The Union Health Ministry is holding discussions with state governments and drug regulatory authorities to consider granting additional...
Torrent Pharma Plans Rs 12,500 Cr Fund Raise Through Secured NCD Issue Written By Parthika Patel6 Jan 2026 2:44 PM ISTNew Delhi: Torrent Pharmaceuticals Limited will raise up to Rs 12,500 crore through the issuance of secured, rated, listed and redeemable...
Shukra Pharma Signs MoU With US Firm for AI Surgical Robotics in India Written By Parthika Patel6 Jan 2026 2:18 PM ISTNew Delhi: Shukra Pharmaceuticals Limited has entered into a Memorandum of Understanding (MoU) with Borns Medical Robotics Inc., USA, for the...
USFDA Approves Agios Pharma's Aqvesme for Alpha, Beta Thalassemia Anemia Written By sheeba farhat6 Jan 2026 2:07 PM ISTThe latest approval is based on a late-stage study in which patients receiving the drug showed a statistically significant increase in hemoglobin...
Punjab Drug Control Books Illegal Chemist in Fazilka Over Habit-Forming Drug Sales Written By Parthika Patel6 Jan 2026 10:30 AM ISTThe drugs were allegedly being sold openly, in clear contravention of provisions of the Drugs and Cosmetics Act and related rules governing the sale...
Jubilant Pharmova Faces Rs 22.1 Cr Income Tax Demand, Plans Rectification Appeal Written By Parthika Patel5 Jan 2026 6:59 PM ISTNew Delhi: Jubilant Pharmova Limited has received an income tax demand of Rs 22.10 crore from the Income Tax Department, DCIT/ACIT (Central),...
Cancer MedTech Gets Clarity: CDSCO Releases Final Oncology Device Risk Classification List Written By Susmita Roy5 Jan 2026 6:27 PM ISTNew Delhi: In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs Standard Control...
Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market Written By sheeba farhat5 Jan 2026 6:19 PM ISTThe Wegovy pill ​could attract new consumers as Novo looks to revive ​its fortunes after profit warnings and sliding shares in 2025.
Post-Patent Semaglutide Boom: Generics Set for Rs 50,000 Cr Revenue Upside Written By sheeba farhat5 Jan 2026 5:39 PM ISTIn India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM)...
Zydus Gets CDSCO Panel Nod to Conduct Phase IV Study of Nelarabine Injection Written By Parthika Patel5 Jan 2026 5:36 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of permission to Zydus...
Hindustan Laboratories Taps Capital Markets, Files IPO Papers with SEBI Written By sheeba farhat5 Jan 2026 5:30 PM ISTThe company proposes to utilize IPO proceeds for funding the working capital requirements and general corporate purposes.
